Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target is not a molecule or receptor in the traditional biochemical sense, but rather a physical phenomenon and engineered agent used to enhance ultrasound imaging. The enhancement relies on the introduction of microbubbles into the bloodstream, which exploit differences in acoustic impedance between their gas core and surrounding tissues or fluids. When exposed to ultrasound waves, these microbubbles resonate—expanding and contracting rapidly—which dramatically increases their reflectivity compared to normal body tissues. This resonance can also be harnessed for targeted drug/gene delivery when combined with focused ultrasound energy.
Microbubbles resonate in response to ultrasound waves due to the large difference in acoustic impedance between the gas core and surrounding tissue, resulting in enhanced echo signals. This resonance can also be used for targeted drug delivery by increasing local membrane permeability or fragmenting bubbles for payload release.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acoustic Impedance Difference (Microbubble Resonance).